Malaria chemoprophylaxis

From IDWiki
Revision as of 18:07, 31 January 2020 by Aidan (talk | contribs) ()
  • Chemoprophylaxis is recommended for travelers to endemic areas
  • Agent chosen based on the local drug-resistance, patient age, and pregnancy status

Choice of Chemoprophylaxis

Chloroquine-sensitive regions

Chloroquine-resistant regions

  • Regions include most of sub-Saharan Africa, South America, Oceania and Asia
    • See the CATMAT list for specific countries
    • Some areas of Thailand, Myanmar (Burma), Laos and Cambodia, and southern Vietnam are both chloroquine-resistant and mefloquine-resistant
  • Drugs of choice

Chloroquine-and mefloquine-resistant regions

  • Regions include Asia, Africa and the Amazon basin, specifically in rural, wooded regions on the Thai borders with Myanmar, Cambodia, and Laos, as well as in southern Vietnam
  • Drugs of choice

Pregnancy

  • Mefloquine can be used, if they cannot avoid travelling to malaria-endemic areas
    • Can cause neuropsychiatric symptoms
  • Atovaquone-proguanil may be considered after the first trimester

Doses

  • Note that the medications that require 4 weeks after end of exposure are extended in this way because they do not treat the liver stage
Medication Dose Duration
Atovaquone-proguanil 250 mg-100 mg po daily 1 day before to 1 week after
Doxycycline 100 mg po daily 1 day before to 4 weeks after
Mefloquine 250 mg po weekly 1-3 weeks before to 4 weeks after
Primaquine 30 mg base po daily 1 day before to 7 days after
Chloroquine 300 mg po weekly 1 week before to 4 weeks after
Hydroxychloroquine 310 mg base po weekly 1 week before to 4 weeks after